Chemiluminescent third-generation assay (amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed

41Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

We assessed the laboratory performance and clinical util-ity of a new commercial third-generation assay of thyroid-stimulating hormone (TSH), Amerlite TSH-30. The interassay CV was 6% at TSH concentrations of ∼0.08 mlU/L, and the analytical and functional detection limits of the assay were 0.005 and 0.0125 mlU/L, respectively. Although the assay recovered ∼96% of TSH International Reference Preparation (TSH-IRP) 80/558 added to serum samples, the endogenous TSH concentrations in basal samples were significantly lower than those found by using two other TSH assays; bias data obtained from thyroliberin stimulation tests suggested that the negative bias found with TSH-30 may be due to the heterogeneity of TSH in basal samples. TSH-30 completely discriminated hyperthyroid and hypothyroid patients from euthyroid ambulatory patients but also detected TSH (>0.0125 mlU/L) in 3 of 46 untreated hyperthyroid patients. Compared with two second-generation assays, TSH-30 better discriminated between patients with subnormal TSH due to hyperthyroidism, thyroxine overreplacement, and nonthyroidal illness but there was still significant overlap between results for these groups.

Cite

CITATION STYLE

APA

Wilkinson, E., Rae, P. W. H., Thomson, K. J. T., Toft, A. D., Spencer, C. A., & Beckett, G. J. (1993). Chemiluminescent third-generation assay (amerlite TSH-30) of thyroid-stimulating hormone in serum or plasma assessed. Clinical Chemistry, 39(10), 2166–2173. https://doi.org/10.1093/clinchem/39.10.2167

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free